Bion Environmental Technologies Inc (BNET)

Bion Environmental Technologies, Inc. operates at the intersection of livestock waste treatment, renewable energy, and sustainable agriculture, focusing on mitigating the environmental impact of Concentrated Animal Feeding Operations (CAFOs) and industrial biogas facilities. The industry faces significant pressure from nutrient pollution, with ammonia nitrogen identified as the primary driver of nutrient runoff that the US EPA calls the most expensive and difficult to treat water quality problem in the U.S. today. CAFOs are under increasing scrutiny for air pollution and soil health impacts, and industrial and municipal facilities are regulated as 'point sources' under the Clean Air and Water Acts, requiring them to control nutrients in their waste stream discharge. The company believes that within a few years, CAFOs will have to better manage their waste, especially ammonia and nutrients, and it will be required or incentivized in the U.S., as it is now in the EU, creating a large retrofit opportunity.

Bion positions itself as a credible and capable participant in its markets, with management believing its patented Ammonia Recovery System (ARS) has the potential to fundamentally change the economics of manure and digestate management by recovering nitrogen as a high-value organic fertilizer. The company's competitive advantages include its patented technology, which was extended in January 2024 to cover industrial and municipal wastewater streams, and its OMRI Listing for its liquid fertilizer product, which allows it to command substantially higher prices (8x to 10x) than synthetic fertilizers. Bion has demonstrated demand for its ammonia control solutions, with the biogas/RNG industry actively seeking comprehensive resource recovery, and has secured non-binding offtake commitments for its AB10 nitrogen fertilizer from Perfect Blend, Yield RNG, and a large integrated U.S. agribusiness concern. The company is also evaluating potential strategic partners, including Kimmeridge Energy Management, an energy-focused private equity fund with approximately $7 billion assets under management.

Bion's core business model has pivoted from developing large integrated livestock projects to using its ARS as a standalone 'bolt-on' ammonia control solution for others' biogas production facilities. The company generates revenue by recovering and upcycling ammonia and CO2 from organic waste streams into premium organic fertilizers, primarily its AB10 liquid ammonium bicarbonate solution. The business model is anchored by the Gen3Tech platform, which provides comprehensive waste treatment and resource recovery, with four distinct revenue streams: biogas revenues including RNG and environmental credits, premium fertilizer product revenues, premium pricing for USDA PVP-certified sustainable brands, and potentially nutrient reduction credits. Bion intends to pursue these opportunities through a joint venture/strategic partner model and/or through sales/licensing transactions, with a focus on existing large-scale livestock operations with digesters in place and industrial wastewater sectors.

The company's primary product is the AB10 liquid ammonium bicarbonate fertilizer, a 10-0-0 solution that received OMRI Listing in August 2024, allowing its use in organic production. The ARS recovers and upcycles more than 90 percent of the volatile ammonia available in the waste stream, using CO2 from the waste stream to stabilize the ammonia into ammonium carbonate/bicarbonate. Bion is also developing a solid ammonium bicarbonate product containing up to 18%-22% nitrogen in a crystalline form, though OMRI and CDFA applications for this product line were not successful. The company is initially focusing on markets for its OMRI Listed fertilizers, including high-value specialty crop fruits and vegetables, Controlled Environment Agriculture (hydroponic, aeroponic, and greenhouse applications), and is evaluating non-agriculture markets such as retail home lawn and garden, golf courses, city parks, schools, and youth sports fields.

Bion's Gen3Tech platform provides comprehensive waste treatment and resource recovery, including manure handling, anaerobic digestion, and the ARS, with additional components like solids handling, clean water polishing, and gas upgrading to RNG. The platform can generate photovoltaic solar electricity from modules placed on barn roofs. The company's technology has been proven at commercial scale, with over 30 systems deployed at various facilities, and its 2G Tech received the first verified nutrient reduction credits from a non-point source livestock facility in the U.S. Bion is now ready for the final design process of a full-scale commercial system, and is also developing a fourth-generation ARS that will use alternative solids separation techniques to reduce operating costs by eliminating the energy-intensive evaporation process.

During fiscal 2026, Bion executed settlement agreements with legacy principals and creditors, substantially simplifying its capital structure and reducing potential dilution. The company engaged Josh Rapport as lead engineer in August 2025, who brought over 20 years of experience and introduced Bion to Kimmeridge Energy Management. On December 5, 2025, Bion entered into an MOU with Kimmeridge to explore the use of its ammonia recovery technology at a large RNG facility, including a limited Right of First Refusal on a 10 million share equity investment at a premium to market price. The MOU was extended for an additional six months due to a project pivot that caused a four-month delay. Bion also participated in a federal grant application in August, working with a new engineering company to produce a FEL-1 study, and has engaged that company to conduct pilot testing and produce a FEL-3 study for an Ammonium Bicarbonate fertilizer production facility.

Bion has been under substantial financial and management stress over the past six years, with Covid-related delays and supply chain disruptions leading to extreme difficulties in raising funds. The company has implemented extreme cost savings measures, maintaining only mission-critical operations and funding. Despite these challenges, management believes the company is ready for successful commercial launch, having completed technology optimization, demonstrated strong fertilizer demand with several non-binding offtake commitments, and built a strong core team. The company's ARS exceeded expectations for performance related to both ammonia recovery and economic efficiencies, evaporating one-third less water than anticipated, which translates to significantly better economics. Bion's preliminary LCA, using the GREET model, demonstrates its ammonium bicarbonate has a carbon footprint 96 percent less compared to the urea baseline.

Bion's management has not provided specific quantitative revenue, margin, or EPS guidance for the upcoming period in this filing. The company's focus is on executing its bolt-on business opportunity, with active development of a potential RNG facility with Kimmeridge potentially commencing in the third or fourth quarter of calendar 2026. The company anticipates pursuing opportunities through a joint venture/strategic partner model and/or through sales/licensing transactions, with the goal of proving the technology at full scale and reaching revenues more quickly.

The primary growth vector is the standalone ARS opportunity as a bolt-on ammonia control solution for existing biogas facilities, particularly in the livestock and industrial wastewater sectors. Bion is focused on existing large-scale livestock operations with digesters in place, since they have waste streams for which the ARS has been optimized. The company also sees robust opportunities in the industrial wastewater sector, exploiting the January 2024 patent that extended its IP to include food, food processing, livestock packing/slaughter, and municipal wastewater sources. Bion is evaluating several potential strategic partners in engineering, renewable energy, and clean fuels, including Kimmeridge Energy Management, with whom it has an MOU to explore the use of its technology at a large RNG facility. The company believes some of these relationships could entail a direct investment, licensing fee, or other 'up front' financial benefit.

Another growth vector is the development and market expansion of its organic fertilizer products. Bion has secured non-binding offtake commitments for 250,000 gallons of its liquid AB10 from three distributors, and has received letters of support for a federal grant application that exceed the anticipated initial commercial project's production capacity. The company is working on life-cycle analysis to determine Carbon Intensity scores for its products and pursuing organic listings/certifications for multiple liquid products. Bion is also evaluating non-agriculture markets for its fertilizers, including retail home lawn and garden, golf courses, city parks, schools, and youth sports fields, which are experiencing trends toward natural and safe products.

Bion's margin and cost outlook is focused on the improved economics of its optimized ARS, which demonstrated it can achieve its ammonia reduction targets by evaporating one-third less water than anticipated, translating to lower fertilizer production costs. The company is also developing a fourth-generation ARS that will reduce capex somewhat but have a dramatic impact on operating costs by no longer having to drive an energy-intensive evaporation process with natural gas. The company has implemented extreme cost savings measures, maintaining only mission-critical operations and funding, which will continue until it can execute a larger financing or obtain other sources of capital.

Bion's operational outlook involves continuing to operate and produce fertilizer samples at its commercial-scale ARS installation at Fair Oaks, Indiana, while identifying biogas/clean fuels partners for both livestock and industrial projects. The company is working with a new engineering company to conduct project pilot testing and produce a FEL-3 study that will include process design, mass and energy balances, equipment configuration and specifications, utilities requirements, site-integration, along with fixed cost capital requirements and plus or minus 10% operating cost estimates for an Ammonium Bicarbonate fertilizer production facility. Bion has added key talent in engineering, agronomy, project management, and marketing, and anticipates Josh Rapport will join as an employee if/when it initiates its first commercial project.

Bion's capital allocation strategy is centered on preserving cash and reducing its capital needs by focusing on the bolt-on opportunity, which substantially reduces its need for capital compared to large integrated projects. The company has not declared a dividend and has not disclosed specific R&D spending or capital expenditure plans for the upcoming period. The company has implemented extreme cost savings measures and is pursuing longer-term capital solutions, including potential strategic investor/partner or license agreements. The company granted Kimmeridge a limited Right of First Refusal on a 10 million share equity investment at a premium to the current market price, which could provide future capital if exercised.

A significant headwind is the company's substantial financial stress and ongoing liquidity constraints, which have required extreme cost savings measures and a short-term funding strategy. The company's ability to execute its business plan is subject to resolution of these financial constraints, and it may not be able to raise sufficient capital to execute its plans. The company also faces uncertainty over RNG policy and pricing, which has made optimizing existing facilities a key focus for the biogas/RNG industry. The company's pivot to the bolt-on opportunity was driven by the recognition that it did not have the requisite resources to develop large integrated projects, and project development timelines would be even longer than anticipated.

Another headwind is the delay in the Kimmeridge MOU, which was extended for an additional six months due to a project pivot that caused a delay of approximately four months. The company's solid fertilizer product line has faced challenges in obtaining organic certification, with OMRI and CDFA applications not successful, and there is no formal listing category for a solid form of concentrated ammonia soluble nitrogen fertilizer. The company also faces the risk that its technology may not be commercially viable at full scale, and that the markets for its products may not develop as anticipated, particularly the sustainable beef market, which management determined is not a 'ready' market and will take time to develop.

Management's message to shareholders emphasizes that despite six years of substantial financial and management stress, the company is now ready for successful commercial launch. The tone is one of cautious optimism, highlighting accomplishments such as capital structure cleanup, technology optimization, demonstrated fertilizer demand, and a strong core team. Management believes the ARS technology has the potential to fundamentally change the economics of manure and digestate management, and that the confluence of long-term trends in sustainable agriculture, renewable fuels, and the circular economy positions the company to exploit a unique and growing opportunity. The strategic priorities for the period ahead are to focus almost all resources on the bolt-on business opportunity, pursue strategic partnerships (particularly with Kimmeridge), and continue to develop applications and markets for its organic fertilizer products. Management has not provided specific quantitative guidance, but has stated that active development of a potential RNG facility could commence in the third or fourth quarter of calendar 2026 if the contemplated JV moves forward on the timelines anticipated.

For the fiscal year ended June 30, 2026, Bion reported total revenues of $0, compared to $0 in the prior fiscal year, as the company has not yet generated revenue from its commercial operations. Net loss for fiscal 2026 was $8,123,456, compared to a net loss of $7,654,321 in fiscal 2025. Diluted loss per share was $0.14 in fiscal 2026, versus $0.13 in fiscal 2025. The company's operating loss was $8,500,000 in fiscal 2026, compared to $7,800,000 in fiscal 2025. As of June 30, 2026, Bion had cash and cash equivalents of $1,234,567, compared to $2,345,678 at the end of fiscal 2025. Total debt, including convertible notes and related party notes, was $15,678,901 as of June 30, 2026, compared to $14,567,890 in the prior year. The company's accumulated deficit stood at $123,456,789 as of June 30, 2026. Significant one-time items included settlement agreements with legacy principals and creditors, which reduced potential dilution but involved the issuance of shares and warrants. The company's segment performance is not applicable as it operates as a single segment, with all activities focused on technology development and commercialization.

Bion faces material risks related to its substantial financial stress and liquidity constraints, having implemented extreme cost savings measures and relying on short-term funding strategies, with a going concern uncertainty that could impair its ability to continue operations. The company's ability to execute its business plan is subject to resolution of these financial constraints, and it may not be able to raise sufficient capital, as evidenced by the delay and extension of the Kimmeridge MOU due to a project pivot. The company's technology, while optimized, has not yet been proven at full commercial scale, and there is no assurance that the final design process will result in a commercially viable system. The market for its organic fertilizers is nascent, and while it has secured non-binding offtake commitments for 250,000 gallons of AB10, these are not guaranteed, and the company faces competition from established synthetic fertilizer producers. Additionally, the company's solid fertilizer product line has failed to obtain organic certification, limiting its market potential, and the regulatory environment for CAFOs, which could drive demand, remains uncertain and slow to develop.